Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
No reason for the revision to the earnings forecast was provided. As reasons for the difference from the previous fiscal year's results, the company cited strong performance in IFMC. sales support, M&A brokerage fees and AI consulting, higher selling, general and administrative expenses resulting from investment in personnel, and the recognition of extraordinary losses.
On a consolidated basis, loss on disposal of fixed assets was ¥3.373 million, office relocation costs were ¥3.263 million, loss on cancellation of leases was ¥2.217 million, impairment loss was ¥0.249 million, and settlement payments were ¥3.600 million, for total extraordinary losses of ¥12.704 million. On a non-consolidated basis, the company recorded ¥141 million in provision for allowance for doubtful accounts related to affiliates, ¥50 million in valuation loss on shares of affiliates, and other items.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥2,608 million（+7.8%） |
| Operating profit | Not disclosed → ¥71 million |
| Ordinary income | Not disclosed → ¥40 million |
| Profit attributable to owners of the parent | Not disclosed → ¥12 million |
| Net income per share | Not disclosed → 8 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥2,419 million; operating loss: ¥123 million; ordinary loss: ¥160 million; net loss attributable to owners of the parent: ¥241 million; net loss per share: ¥159.28 |
| Reason for the revision | No reason for the revision to the earnings forecast was provided. As reasons for the difference from the previous fiscal year's results, the company cited strong performance in IFMC. sales support, M&A brokerage fees and AI consulting, higher selling, general and administrative expenses resulting from investment in personnel, and the recognition of extraordinary losses. |
| Details and amount of extraordinary loss | On a consolidated basis, loss on disposal of fixed assets was ¥3.373 million, office relocation costs were ¥3.263 million, loss on cancellation of leases was ¥2.217 million, impairment loss was ¥0.249 million, and settlement payments were ¥3.600 million, for total extraordinary losses of ¥12.704 million. On a non-consolidated basis, the company recorded ¥141 million in provision for allowance for doubtful accounts related to affiliates, ¥50 million in valuation loss on shares of affiliates, and other items. |
| Dividend forecast revision | The full-year dividend forecast for the fiscal year ending March 2027 is ¥0.00. No disclosure was made regarding a revision to the dividend forecast: Not disclosed. |
| Consolidated / non-consolidated | Consolidated / non-consolidated (standalone) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited the recovery in health-support sales through IFMC. sales support, strong performance in high-gross-margin offerings such as M&A brokerage fees and AI consulting, higher selling, general and administrative expenses resulting from investment in personnel to expand the sales workforce, and the recognition of extraordinary losses as factors behind the difference from the previous fiscal year's results. For the outlook, it cited the continuation of IFMC. sales support, product development, a review of the organizational structure in light of business realignment, and optimization of selling, general and administrative expenses.